|
WO2012126777A1
|
|
Inhibition of neuraminidase activity
|
|
BR112012015202A2
|
|
use of iota- and / or kappa-carrageenan together with a neuraminidase inhibitor, and pharmaceutical composition
|
|
MX2010013567A
|
|
Antiallergic marine biopolymers.
|
|
EP2186523A1
|
|
Use of escin for treatment of Type IV hypersensitivity reaction
|
|
CN101784272A
|
|
Antiviral composition comprising sulfated polysaccharide
|
|
CA2671317A1
|
|
Antiviral composition and method of use
|
|
WO2007112966A1
|
|
Cellulose sulfate for the treatment of rhinovirus infection
|
|
US2008131454A1
|
|
Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
|
|
EP1930015A1
|
|
Use of carrageenan for treating rhinovirus infections
|
|
EP1884245A1
|
|
Use of Escin
|
|
EP1842545A1
|
|
Anti-inflammatory polymer
|
|
EP1842546A1
|
|
Cellulose sulfate for the treatment of rhinovirus infection
|
